Amiodarone-induced thyrotoxicosis: Something new to refine the initial diagnosis?

European Journal of Endocrinology

Volumn 159, Issue 4, 2008, Pages 359-361

  Tanda, Maria Laura ^a   Bogazzi, Fausto ^b   Martino, Enio ^b   Bartalena, Luigi ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; C REACTIVE PROTEIN; GLUCOCORTICOID; INTERLEUKIN 6; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; POTASSIUM PERCHLORATE; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROGLOBULIN; ANTIARRHYTHMIC AGENT;

AMIODARONE INDUCED THYROTOXICOSIS; AMIODARONE INDUCED THYROTOXICOSIS TYPE 1; AMIODARONE INDUCED THYROTOXICOSIS TYPE 2; COMBINATION CHEMOTHERAPY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EUTHYROIDISM; HUMAN; HYPOTHYROIDISM; MONOTHERAPY; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THYROID HORMONE SYNTHESIS; THYROIDITIS; THYROTOXICOSIS; CHEMICALLY INDUCED DISORDER; HEART DISEASE; REVIEW;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; HEART DISEASES; HUMANS; THYROTOXICOSIS;

EID: 54049114241     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0553     Document Type: Note

References (18)

1. Martino E, Bartalena L, Bogazzi F & Braverman LE. The effects of amiodarone on the thyroid. Endocrine Reviews 2001 22 240-254.
2. O'Sullivan AJ, Lewis M & Diamond T. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. European Journal of Endocrinology 2006 154 533-536.
3. Bogazzi F, Bartalena L, Tomisti L, Dell'Unto E, Cosci C, Sardella C, Tanda ML, Lai A, Gasperi M, Aghini-Lombardi F & Martino E. Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy. Journal of Endocrinological Investigation 2008 31 515-519.
4. Bogazzi F, Bartalena L, Gasperi M, Braverman LE & Martino E. The various effects of amiodarone on thyroid function. Thyroid 2001 11 511-519.
5. Bogazzi F, Dell'Unto E, Tanda ML, Tomisti L, Cosci C, Aghini-Lombardi F, Sardella C, Pinchera A, Bartalena L & Martino E. Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis. Journal of Endocrinological Investigation 2007 29 694-699.
6. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A & Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. Journal of Clinical Endocrinology and Metabolism 1996 81 2930-2933.
7. Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell'Unto E, Aghini-Lombardi F & Martino E. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. Journal of Clinical Endocrinology and Metabolism 2007 92 556-562.
8. Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A & Martino E. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clinical Endocrinology 2007 67 533-537.
9. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A & Martino E. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clinical Endocrinology 2004 61 494-502.
10. Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC & Wiersinga WM. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clinical Endocrinology 2006 65 433-438.
11. Tanda ML, Piantanida E, Lai A, Liparulo G, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E & Bartalena L. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North Americans and European thyroidologists. Clinical Endocrinology, 2008. Epub ahead of print.
12. Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini-Lombardi F, Ceccarelli C, Pinchera A, Bartalena L & Braverman LE. Thyroid color flow Doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. Journal of Endocrinological Investigation 2003 26 635-640.
13. Loy M, Perra E, Melis A, Cianchetti ME, Piga M, Serra A, Pinna G & Mariotti S. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Acta Radiologica 2007 48 628-634.
14. Bartatena L, Brogioni S, Grasso L, Rago T, Vitti P & Martino E. Interleukin-6: a marker of thyroid-destructive processes? Journal of Clinical Endocrinology and Metabolism 1994 79 1424-1427.
15. Daniels GH. Amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 2001 86 3-8.
16. Eaton SEM, Euinton HA, Newman CM, Weetman AP & Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clinical Endocrinology 2002 56 33-38.
17. Pearce EN, Bogazzi F, Martino E, Brogioni S, Pardini E, Pellegrini G, Parkes AB, Lazarus JH, Pinchera A & Braverman LE. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid 2003 13 643-648.
18. 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. European Journal of Endocrinology 2008 159 423-429.